Change Grow Live and Gilead Sciences form partnership to help eliminate hepatitis C
National health and social care charity Change Grow Live is collaborating with Gilead to identify and treat people with Hepatitis C, as part of a wider NHS initiative to eliminate the virus by 2025.
The collaboration will see both parties combine their expertise and resources to improve health outcomes for people who have or are at risk of Hepatitis C. As the biggest drug and alcohol treatment provider in the UK, Change Grow Live will appoint dedicated Hepatitis C Coordinators, who will work with their nationwide services to identify the service users most at risk of infection or who already have a Hepatitis C positive diagnosis.
By using a method of detection known as ‘Dried Blood Spot Testing’, Change Grow Live will identify service users who have Hepatitis C and work with specialist NHS services to provide treatment. By identifying those most at risk of contracting the blood borne virus, Change Grow Live and Gilead hope to spread the message that Hepatitis C is preventable and treatable with little or no side effects.
Stacey Smith, Director of Nursing and Clinical Practice at Change Grow Live, said:
‘Change Grow Live is really excited to be working in partnership with Gilead to advance testing and treatment of Hepatitis C to help achieve our ultimate goal of eliminating the virus in England as soon as possible. By encouraging our service users to seek a diagnosis, we aim to address a lot of the misconceptions around blood borne viruses, whilst offering holistic treatment services that can help our service users and their families live their best possible lives.’
Hilary Hutton-Squire, General Manager UK and Ireland at Gilead said:
‘As part of Gilead’s commitment to eliminating Hepatitis C we are proud to be working with partners such as Change Grow Live on initiatives that have the potential to change many lives. By ensuring those at risk are tested and treated within appropriate community settings we can vastly improve the number of patients successfully achieving a cure and make big steps towards elimination’